OPEN: 2027 IMS Career Development Award. Full applications due January 29, 2027 at 11:59 p.m. EST.
International — IMS 2027 Career Development Research Grants (Up to $75,000; January 29 EST)
2027 IMS Career Development Award. Up to $75,000 USD for an individual one-year career development award, inclusive of permitted institutional overhead up to 8%. Approximately $3 million is the combined 2027 IMS research program pool, not an applicant award ceiling. Due January 29, 2027 at 11:59 p.m. EST; specific investigator qualifications and award restrictions apply.
FundingUp to $75,000 USD for an individual one-year career development award, inclusive of permitted institutional overhead up to 8%. Approximately $3 million is the combined 2027 IMS research program pool, not an applicant award ceiling.
DeadlineOPEN. Full application due January 29, 2027 at 11:59 p.m. Eastern Standard Time. The current controlling program documentation and IMS announcement agree on this deadline.
Last verified2026-11-06
Required next actionCheck eligibility (Emerging scientist with M.D. or Ph.D., or currently completing a Ph.D. in plasma cell dyscrasia research, who is not yet an independent investigator, has not received NIH independent research funding or an international equivalent, and plans a research career in plasma cell disorders. Applicant must arrange a distinct host laboratory outside their home institution and local metropolitan area; existing employment agreement with the host laboratory is disqualifying. Home- or host-institution PI must be an IMS member. Host labs may submit one application per cycle.) and controlling instructions https://www.myelomasociety.org/grants/ims-career-development-award/; register/login to https://myelomasociety.flexigrant.com/; prepare Home-institution-approved research application, up to five-page proposal including one-page specific aims, up to 25 references, career development statement, applicant CV, home/host PI biosketches, signed letters from home institution and separate host mentor, itemized budget and justification. Submit complete application by January 29, 2027 at 11:59 p.m. Eastern Standard Time.
Broad Eligibility
Emerging scientist with M.D. or Ph.D., or currently completing a Ph.D. in plasma cell dyscrasia research, who is not yet an independent investigator, has not received NIH independent research funding or an international equivalent, and plans a research career in plasma cell disorders. Applicant must arrange a distinct host laboratory outside their home institution and local metropolitan area; existing employment agreement with the host laboratory is disqualifying. Home- or host-institution PI must be an IMS member. Host labs may submit one application per cycle.
Atlas Analysis
Official 2027 IMS 2027 IMS Career Development Award guidelines, October 15 2026 funder announcement, and live IMS grant application portal reviewed November 6, 2026. Distinct 2027 award mechanism IMS-CAREER-DEVELOPMENT-2027. Applicant funding Up to $75,000 USD for an individual one-year career development award, inclusive of permitted institutional overhead up to 8%. Approximately $3 million is the combined 2027 IMS research program pool, not an applicant award ceiling. Research scope Career development and cross-institution research mentorship in multiple myeloma and other plasma cell disorders. Controls: Allowable funds may cover one year of career salary, visa-status adjustment and eligible travel; host laboratory is expected to supply research consumables, laboratory equipment and animal research costs. Institutional overhead up to 8% is inside the $75,000 award ceiling. A mentor at the distinct host lab must provide written support; formal cost share not stated in the solicitation. Duplicate search included all published and unpublished WordPress grant titles and sources for IMS, Myeloma Society, Riney, Plasma Cell, Translational Research and Career Development; no same track-year solicitation found.
Grant opportunity
The 2027 IMS Career Development Award is a genuine competitive funding opportunity from the International Myeloma Society (IMS) and, for the translational mechanism, the Paula and Rodger Riney Foundation. The newly open 2027 cycle supports Career development and cross-institution research mentorship in multiple myeloma and other plasma cell disorders.
Applicant-level funding and deadline
Up to $75,000 USD for an individual one-year career development award, inclusive of permitted institutional overhead up to 8%. Approximately $3 million is the combined 2027 IMS research program pool, not an applicant award ceiling. Applications are due January 29, 2027 at 11:59 p.m. Eastern Standard Time. This is a full research application, not a preliminary registration or an invitation to government vendor procurement. The combined funding pool announced for both IMS mechanisms exceeds $3 million, separate from individual award limits.
Eligibility and research fit
Emerging scientist with M.D. or Ph.D., or currently completing a Ph.D. in plasma cell dyscrasia research, who is not yet an independent investigator, has not received NIH independent research funding or an international equivalent, and plans a research career in plasma cell disorders. Applicant must arrange a distinct host laboratory outside their home institution and local metropolitan area; existing employment agreement with the host laboratory is disqualifying. Home- or host-institution PI must be an IMS member. Host labs may submit one application per cycle. Applicants should follow the precise official track-specific restrictions, including research appointment, mentorship, host requirements and IMS membership where applicable.
Allowable costs and restrictions
Allowable funds may cover one year of career salary, visa-status adjustment and eligible travel; host laboratory is expected to supply research consumables, laboratory equipment and animal research costs. Institutional overhead up to 8% is inside the $75,000 award ceiling. A mentor at the distinct host lab must provide written support; formal cost share not stated in the solicitation. Applications undergo scientific review, and only research aligned with the stated award purpose qualifies.
Application instructions
Submit via the official IMS grant management portal (FlexiGrant). Registration for a grant-portal account is required. The track-specific application packet requires: Home-institution-approved research application, up to five-page proposal including one-page specific aims, up to 25 references, career development statement, applicant CV, home/host PI biosketches, signed letters from home institution and separate host mentor, itemized budget and justification. Read the controlling IMS 2027 award instructions and October 15, 2026 funding announcement before submission. Last verified: November 6, 2026.
Source verificationReferenced source · www.myelomasociety.orgAtlas last verified this record 2026-11-06. Always use the funder's current application materials, amendments and portal instructions as the controlling source.View source and application materials ↗
